DE602007004018D1 - Imidazolcarbonsäurealkylester-haltiges Medikament zur Behandlung neurodegenerativer Erkrankungen - Google Patents

Imidazolcarbonsäurealkylester-haltiges Medikament zur Behandlung neurodegenerativer Erkrankungen

Info

Publication number
DE602007004018D1
DE602007004018D1 DE602007004018T DE602007004018T DE602007004018D1 DE 602007004018 D1 DE602007004018 D1 DE 602007004018D1 DE 602007004018 T DE602007004018 T DE 602007004018T DE 602007004018 T DE602007004018 T DE 602007004018T DE 602007004018 D1 DE602007004018 D1 DE 602007004018D1
Authority
DE
Germany
Prior art keywords
mcg
treatment
administered
neurodegenerative diseases
imidazolecarboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007004018T
Other languages
English (en)
Inventor
Elaine A Delack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedDEV Inc
Original Assignee
MedDEV Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedDEV Inc filed Critical MedDEV Inc
Publication of DE602007004018D1 publication Critical patent/DE602007004018D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602007004018T 2006-05-23 2007-05-23 Imidazolcarbonsäurealkylester-haltiges Medikament zur Behandlung neurodegenerativer Erkrankungen Active DE602007004018D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80803206P 2006-05-23 2006-05-23

Publications (1)

Publication Number Publication Date
DE602007004018D1 true DE602007004018D1 (de) 2010-02-11

Family

ID=38469973

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007004018T Active DE602007004018D1 (de) 2006-05-23 2007-05-23 Imidazolcarbonsäurealkylester-haltiges Medikament zur Behandlung neurodegenerativer Erkrankungen

Country Status (7)

Country Link
US (1) US7666893B2 (de)
EP (1) EP1859800B1 (de)
AT (1) ATE453392T1 (de)
AU (1) AU2007202334A1 (de)
CA (1) CA2589819C (de)
DE (1) DE602007004018D1 (de)
NZ (1) NZ555337A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9737552B2 (en) 2010-12-14 2017-08-22 The Johns Hopkins University Treatment of cognitive impairment in a subject with a neurological autoimmune disease
EP4338740A1 (de) 2022-09-13 2024-03-20 Johannes Gutenberg-Universität Mainz Transdermales pflaster zur förderung oder beschleunigung der myelinisierung und/oder remyelinisierung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055573A (en) 1976-05-06 1977-10-25 Smithkline Corporation Electrochemical reduction of imidazolecarboxylic esters
US6426360B1 (en) * 1994-07-28 2002-07-30 G D Searle & Co. 4,5-substituted imidazolyl compounds for the treatment of inflammation
US6514977B1 (en) 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors
CA2336004C (en) 1998-06-26 2006-10-24 Elaine A. Delack Use of histamine h2 agonists for the treatment of multiple sclerosis
US6359145B1 (en) 1998-07-23 2002-03-19 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
AUPP921299A0 (en) 1999-03-15 1999-04-15 Fujisawa Pharmaceutical Co., Ltd. New heterocyclic compounds

Also Published As

Publication number Publication date
EP1859800A1 (de) 2007-11-28
CA2589819C (en) 2015-07-07
CA2589819A1 (en) 2007-11-23
US20070276021A1 (en) 2007-11-29
NZ555337A (en) 2009-03-31
ATE453392T1 (de) 2010-01-15
AU2007202334A1 (en) 2007-12-13
EP1859800B1 (de) 2009-12-30
US7666893B2 (en) 2010-02-23

Similar Documents

Publication Publication Date Title
HRP20191029T1 (hr) Derivati morfinana radi liječenja predoziranja lijekom
JP2006231070A5 (de)
KR20100088160A (ko) Ｃｍｔ 및 관련 장애를 치료하기 위한 신규 치료적 접근법
EA201500553A1 (ru) Многодневный пластырь для чрескожного введения ротиготина
RU2015107877A (ru) Способы лечения болезни альцгеймера и фармацевтические композиции
EP2756843A3 (de) Positiv geladene, wasserlösliche Prodrugs von Diclofenac mit sehr schneller Hautpenetrationsrate
CA2601715A1 (en) Dosage regimen for the treatment of a traumatic brain injury with progesterone
RU2008138381A (ru) Режимы дозирования адреналина
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
MY142431A (en) Oxadiazolones, processes for their preparation and their use as pharmaceuticals
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
MX2007006637A (es) Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa.
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
US20140045801A1 (en) Pramipexole transdermal delivery for severe headaches
JP2015524423A5 (de)
US20210169859A1 (en) Treatment and management of augmentation in restless legs syndrome
JP2016505050A5 (de)
DE602007004018D1 (de) Imidazolcarbonsäurealkylester-haltiges Medikament zur Behandlung neurodegenerativer Erkrankungen
DE602007014193D1 (de) Behandlung psychiatrischer patienten mit schlafstörungen und/oder übermässiger tagesschläfrigkeit mit paliperidon
TW200724138A (en) Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
JP2021105050A (ja) レビー小体病の治療および／または予防剤
MX2018005298A (es) Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa.
RU2008152691A (ru) Способ профилактики и лечения мастита у коров
JP6869893B2 (ja) 前頭葉機能障害治療剤
RU2014147728A (ru) Производное транс-2-деценовой кислоты и содержащее его лекарственное средство

Legal Events

Date Code Title Description
8364 No opposition during term of opposition